A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Site JP00003, Aichi

Site JP00005, Aichi

Site JP00042, Aichi

Site JP00044, Aichi

Site JP00020, Chiba

Site JP00010, Ehime

Site JP00021, Ehime

Site JP00013, Fukuoka

Site JP00011, Fukushima

Site JP00035, Fukushima

Site JP00017, Gifu

Site JP00033, Gifu

Site JP00012, Gunma

Site JP00016, Gunma

Site JP00025, Gunma

Site JP00046, Hiroshima

Site JP00015, Hokkaido

Site JP00023, Hokkaido

Site JP00028, Hokkaido

Site JP00038, Hokkaido

Site JP00040, Hokkaido

Site JP00045, Hokkaido

Site JP00034, Hyōgo

Site JP00008, Ibaraki

Site JP00018, Ibaraki

Site JP00027, Ibaraki

Site JP00030, Ibaraki

Site JP00022, Ishikawa

Site JP00041, Kagoshima

Site JP00031, Kumamoto

Site JP00037, Kumamoto

Site JP00009, Nagano

Site JP00014, Nagano

Site JP00026, Nagano

Site JP00047, Nagano

Site JP00002, Niigata

Site JP00029, Niigata

Site JP00039, Okayama

Site JP00024, Okinawa

Site JP00036, Osaka

Site JP00006, Saitama

Site JP00032, Shizuoka

Site JP00043, Tokushima

Site JP00048, Tokyo

Site JP00007, Tottori

Site JP00019, Toyama

Site JP00004, Yamaguchi